DigestRedComo funciona
Red
/
Empresas
Ar
No verificado

Arrowhead Pharmaceuticals, Inc.

Sobre qué escribimos

BiotecnologíaCienciaFarmacéuticaMedicina - VariosSalud

90 Comunicados de prensa

Ver todos los comunicados de prensa
04/08/2026
Web y redes sociales
Telefonía
Eventos
Mercado de valores
Cardiología
Biotecnología
Farmacéutica
Salud
Higiene alimentaria
Medicina - Varios
Arrowhead Pharmaceuticals Reports Fiscal 2026 Third Quarter Results
Fuente
Arrowhead Pharmaceuticals, Inc.
Editor
Business Wire
1.00
0
04/08/2026
Biotecnología
Higiene alimentaria
Salud
Farmacéutica
Medicina - Varios
Arrowhead Pharmaceuticals Acquires FDA Priority Review Voucher
Fuente
Arrowhead Pharmaceuticals, Inc.
Editor
Business Wire
1.00
0
03/08/2026
Mercado de valores
Finanzas
Salud
Biotecnología
Medicina - Varios
Ciencia
Farmacéutica
Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Fuente
Arrowhead Pharmaceuticals, Inc.
Editor
Business Wire
1.00
0
22/07/2026
Web y redes sociales
Telefonía
Eventos
Industria
Ciencia
Cardiología
Biotecnología
Farmacéutica
Salud
Medicina - Varios
Arrowhead Pharmaceuticals Reports Topline Results from Phase 3 SHASTA-3 and SHASTA-4 Studies of Plozasiran in Patients with Severe Hypertriglyceridemia
Fuente
Arrowhead Pharmaceuticals, Inc.
Editor
Business Wire
1.00
0
21/07/2026
Web y redes sociales
Telefonía
Finanzas
Mercado de valores
Salud
Biotecnología
Medicina - Varios
Ciencia
Farmacéutica
Arrowhead Pharmaceuticals to Webcast Fiscal 2026 Third Quarter Results
Fuente
Arrowhead Pharmaceuticals, Inc.
Editor
Business Wire
1.00
0
22/06/2026
Industria
Ciencia
Sanidad
Farmacéutica
Oncología
VIH, SIDA y enfermedades autoinmunes
Biotecnología
Medicina - Varios
Higiene alimentaria
Salud
Arrowhead Pharmaceuticals Receives Marketing Authorization in the European Union for REDEMPLO® (plozasiran) to Reduce Triglycerides in Adults with Familial Chylomicronemia Syndrome (FCS)
Fuente
Arrowhead Pharmaceuticals, Inc.
Editor
Business Wire
1.00
0
18/06/2026
Web y redes sociales
Ciencia
Biotecnología
Salud
Medicina - Varios
Cardiología
Sanidad
Farmacéutica
Arrowhead Pharmaceuticals to Host a Webinar on its Cardiometabolic Pipeline as Part I of the 2026 Summer Series of R&D Webinars
Fuente
Arrowhead Pharmaceuticals, Inc.
Editor
Business Wire
1.00
0
02/06/2026
Eventos
Biotecnología
Salud
Farmacéutica
Medicina - Varios
Arrowhead Pharmaceuticals to Participate in Upcoming June 2026 Events
Fuente
Arrowhead Pharmaceuticals, Inc.
Editor
Business Wire
1.00
0
27/05/2026
Ciencia
Salud
Biotecnología
Medicina - Varios
Sanidad
Farmacéutica
Eventos
Industria
Arrowhead Pharmaceuticals Presents New Clinical Data on RNAi-based Obesity and MASH Candidate ARO-INHBE at EASL 2026
Fuente
Arrowhead Pharmaceuticals, Inc.
Editor
Business Wire
1.00
0
26/05/2026
Web y redes sociales
Eventos
Industria
Salud
Biotecnología
Medicina - Varios
Farmacéutica
Cardiología
Arrowhead Pharmaceuticals Presents New Positive Clinical Cardiometabolic Data at the 94th European Atherosclerosis Society (EAS) Congress
Fuente
Arrowhead Pharmaceuticals, Inc.
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0